Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determination of Exosome Mitochondrial DNA as a Biomarker of Renal Cancer Aggressiveness

31 Dec 2021

Abstract excerpt

Here, the role of non-invasive biomarkers in liquid biopsy was evaluated, mainly in exosomes and mitochondrial DNA (mtDNA) as promising, novel, and stable biomarkers for renal cell carcinoma (RCC). A total of 140 fractions (named from B to F) obtained by ultracentrifugations of whole blood samples from 28 individuals (13 patients and 15 controls) were included. Nanoparticle Tracking Analysis (NTA) was conducted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Extracellular vesicles in disease
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35008363
DOI: 10.3390/cancers14010199

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determination of Exosome Mitochondrial DNA as a Biomarker of Renal Cancer AggressivenessPMID 35008363Read ↗

Determination of Exosome Mitochondrial DNA as a Biomarker of Renal Cancer AggressivenessSemantic proximity Read ↗

Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinomaSemantic proximity Read ↗

Molecular characterization and diagnostic criteria of renal cell carcinoma with emphasis on liquid biopsiesSemantic proximity Read ↗

Circulating Non-coding RNAs in Renal Cell Carcinoma—Pathogenesis and Potential Implications as Clinical BiomarkersSemantic proximity Read ↗

Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid BiopsySemantic proximity Read ↗

Next-Generation Sequencing-Based Analysis of Urine Cell-Free mtDNA Reveals Aberrant Fragmentation and Mutation Profile in Cancer Patients.Semantic proximity Read ↗

Urinary circRNA Biomarkers for Non-Invasive Renal Cell Carcinoma Detection Identified via Whole-Exome RNA SequencingSemantic proximity Read ↗

Urinary cell-free DNA as a noninvasive liquid biopsy for hepatocellular carcinoma: a novel tool for diagnostics and monitoringSemantic proximity Read ↗

Clinical Utility of Exosomal Rna in Cancer Pathology and Therapeutic MonitoringSemantic proximity Read ↗

Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinomaSemantic proximity Read ↗

Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy TestsSemantic proximity Read ↗

Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.